Interchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making?
Bruna de Oliveira AscefRenan Gonçalves Leonel da SilvaHaliton Alves de Oliveira JúniorPatricia Coelho De SoárezPublished in: Cadernos de saude publica (2019)